Elanco Animal Health Incorporated

Equities

ELAN

US28414H1032

Pharmaceuticals

Market Closed - Nyse 04:00:02 2024-03-28 pm EDT 5-day change 1st Jan Change
16.28 USD +0.68% Intraday chart for Elanco Animal Health Incorporated -0.12% +9.26%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Transcript : Elanco Animal Health Incorporated Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-12-2024 04:05 PM
Elanco Animal Health Insider Bought Shares Worth $322,808, According to a Recent SEC Filing MT
Transcript : Elanco Animal Health Incorporated Presents at TD Cowen 44th Annual Health Care Conference 2024, Mar-04-2024 10:30 AM
Elanco Animal Health Incorporated Appoints Shiv O'Neill as Executive Vice President, General Counsel and Corporate Secretary CI
Elanco Animal Health Incorporated Sends Communication to its Employees CI
Elanco Animal Health Incorporated Issues a Statement in Response to the Submission of Nominees by Ancora Holdings Group CI
Ancora seeks four board seats at Elanco amid push for changes RE
Elanco Animal Health Issues Response to Ancora Holdings' Board Nominations MT
Transcript : Elanco Animal Health Incorporated Presents at Bank of America 2024 Animal Health Virtual Summit, Feb-29-2024 02:10 PM
Elanco Animal Health Shareholder Ancora Pushes for Board Refresh, Chief Executive Succession Plan MT
Ancora Nominates Candidates to Elanco Animal Health Board CI
Ancora seeks four board seats at Elanco amid push for changes, sources say RE
Morgan Stanley Adjusts Elanco Animal Health's Price Target to $17 From $16, Keeps Overweight Rating MT
Goldman Sachs Raises Price Target on Elanco Animal Health to $14 From $12.50, Maintains Sell Rating MT
Barclays Adjusts Price Target on Elanco Animal Health to $19 From $18, Maintains Overweight Rating MT
Sector Update: Health Care Stocks Mixed Premarket Monday MT
Transcript : Elanco Animal Health Incorporated, Q4 2023 Earnings Call, Feb 26, 2024
Elanco Animal Health's Q4 Adjusted Earnings Fall, Revenue Rises; 2024 Guidance Issued MT
Elanco Animal Health Incorporated Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 CI
Earnings Flash (ELAN) ELANCO ANIMAL HEALTH Posts Q4 Revenue $1.04B, vs. Street Est of $1B MT
Earnings Flash (ELAN) ELANCO ANIMAL HEALTH Posts Q4 EPS $0.08, vs. Street Est of $0.10 MT
Earnings Flash (ELAN) ELANCO ANIMAL HEALTH Posts Q4 EPS $0.08, vs. Street Est of $0.10 MT
Elanco Animal Health Incorporated Provides Earnings Guidance for the First Quarter and Full Year 2024 CI
Cattler Launches Interface with Elanco for Its Benchmark Program CI
Sector Update: Health Care Stocks Rise Late Afternoon MT
Chart Elanco Animal Health Incorporated
More charts
Elanco Animal Health Incorporated is an animal health company. The Company is focused in delivering products and services to prevent and treat disease in farm animals and pets. Its portfolio serves animals across its core species consisting of dogs, cats and cattle, poultry, swine, sheep and aqua. It offers products in two primary categories: Pet Health and Farm Animal. Its Pet Health portfolio is focused on parasiticides, vaccines and therapeutics. Its Pet Health portfolio products that protect pets from fleas, ticks and internal parasites. Its Farm Animal portfolio of products is primarily focused on cattle, swine, poultry, and aquaculture. Its Pet Health products include Advantage Family, Atopica, Claro/ Neptra, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, and TruCan. Its Farm Animal products include AviPro, Baycox, Catosal, Comforta, Denagard, Experior, Hemicell, Maxiban, Monteban, Pulmotil, Rumensin, and others.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
16.28 USD
Average target price
17.09 USD
Spread / Average Target
+4.98%
Consensus
  1. Stock
  2. Equities
  3. Stock Elanco Animal Health Incorporated - Nyse
  4. News Elanco Animal Health Incorporated
  5. Stifel Lowers Elanco Animal Health to Hold From Buy, Price Target to $34 From $37